Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin versus erythromycin for preterm premature rupture of membranes
IRCT20190601043785N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of azithromycin and erythromycin in Preterm prelabor rupture of membranes (PPROM) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Duration of pregnancy and Neonatal complication. Started Jul 2019; status: completed.
02
Drugs
azithromycinerythromycin
03
Conditions
Preterm prelabor rupture of membranes (PPROM)
Beyond the preview
Go deeper on IRCT20190601043785N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190601043785N1.